Patents Assigned to SATOR THERAPEUTICS
  • Optimized oncolytic viruses and uses thereof
    Patent number: 12521424
    Abstract: Methods of inhibiting or reducing tumor growth are disclosed. A composition containing at least one selected oncolytic virus is administered within a tumor of a patient. The virus kills cancerous cells and induces a systemic and lasting anti-tumor immunity that is also compatible with other cancer treatments. Also disclosed are methods of creating synthetic viruses for targeting cancerous tumors.
    Type: Grant
    Filed: December 6, 2021
    Date of Patent: January 13, 2026
    Assignee: SATOR THERAPEUTICS
    Inventors: Peter M. Chumakov, Anastasia V. Lipatova, Stepan P. Chumakov, Natalia D. Tararova, Stephen A. Charles, Anton A. Komar
  • Optimized oncolytic viruses and uses thereof
    Patent number: 12357664
    Abstract: Methods of inhibiting or reducing tumor growth are disclosed. A composition containing at least one selected oncolytic virus is administered within a tumor of a patient. The virus kills cancerous cells and induces a systemic and lasting anti-tumor immunity that is also compatible with other cancer treatments. Also disclosed are methods of creating synthetic viruses for targeting cancerous tumors.
    Type: Grant
    Filed: December 6, 2021
    Date of Patent: July 15, 2025
    Assignee: SATOR THERAPEUTICS
    Inventors: Peter M. Chumakov, Anastasia V. Lipatova, Stepan P. Chumakov, Natalia D. Tararova, Stephen A. Charles, Anton A. Komar